MACROPHAGE RESPONSES IN INFLAMMATORY DEMYELINATING NEUROPATHIES

被引:65
|
作者
GRIFFIN, JW
STOLL, G
LI, CY
TYOR, W
CORNBLATH, DR
机构
[1] Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland
[2] Department of Neurology, University of Dusseldorf
关键词
D O I
10.1002/ana.410270717
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Macrophages are prominent participants in inflammatory demyelinating neuropathies. To provide a different means of evaluating macrophage behavior, we used immunostaining of teased nerve fibers and endoneurial blood vessels. We assessed the frequency with which macrophages were seen in inflammatory demyelinating neuropathies, their relationship to normal and demyelinating fibers, and their expression of major histocompatibility Class II markers (Ia antigen). In 6 patients with chronic inflammatory neuropathy and 1 with Guillain‐Barré syndrome, we found regularly that macrophages were adherent to teased blood vessels. Cells presumed to be entering the nerve were elongated, often with a polarized appearance suggesting motility, and were Ia‐positive. After entry into nerve, the Ia‐positive macrophages were adherent to both normal and demyelinating fibers. They often retained their Ia positivity after penetrating into the nerve fiber and removing myelin. Foamy macrophages, judged to be postphagocytic, were Ia‐negative. The foamy macrophages found adhering to blood vessels were presumed to be leaving the nerve. This pattern of entry as Ia‐positive prephagocytic cells and evolution to Ia‐negative foamy macrophages was compared with other experimental and human neuropathies. Copyright © 1990 American Neurological Association
引用
收藏
页码:S64 / S68
页数:5
相关论文
共 50 条
  • [1] Inflammatory demyelinating neuropathies
    Muley, Suraj Ashok
    Parry, Gareth J.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2009, 11 (03) : 221 - 227
  • [2] Inflammatory Demyelinating Neuropathies
    Lopate, Glenn
    Pestronk, Alan
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2011, 13 (02) : 131 - 142
  • [3] Inflammatory demyelinating neuropathies
    Suraj Ashok Muley
    Gareth J. Parry
    Current Treatment Options in Neurology, 2009, 11 : 221 - 227
  • [4] Inflammatory Demyelinating Neuropathies
    Glenn Lopate
    Alan Pestronk
    Current Treatment Options in Neurology, 2011, 13 : 131 - 142
  • [5] PATHOLOGY OF INFLAMMATORY DEMYELINATING NEUROPATHIES
    PRINEAS, JW
    BAILLIERES CLINICAL NEUROLOGY, 1994, 3 (01): : 1 - 24
  • [6] Behind the pathology of macrophage-associated demyelination in inflammatory neuropathies: demyelinating Schwann cells
    Park, Hwan Tae
    Kim, Young Hee
    Lee, Kyung Eun
    Kim, Jong Kuk
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2020, 77 (13) : 2497 - 2506
  • [7] Behind the pathology of macrophage-associated demyelination in inflammatory neuropathies: demyelinating Schwann cells
    Hwan Tae Park
    Young Hee Kim
    Kyung Eun Lee
    Jong Kuk Kim
    Cellular and Molecular Life Sciences, 2020, 77 : 2497 - 2506
  • [8] Treatment of chronic inflammatory demyelinating neuropathies
    Leger, J. -M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 13 - 13
  • [9] Apheresis in treatment of the inflammatory demyelinating peripheral neuropathies
    Kincaid, JC
    THERAPEUTIC APHERESIS, 2002, 6 (01): : 53 - 56
  • [10] Atypical varieties of chronic inflammatory demyelinating neuropathies
    Dyck, PJ
    Dyck, PJB
    LANCET, 2000, 355 (9212): : 1293 - 1294